Your SlideShare is downloading. ×
The Journal Club FMDU 1st meeting – 24 may 2012
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

The Journal Club FMDU 1st meeting – 24 may 2012

1,835

Published on

The Journal Club of the Faculty of Medicine Diponegoro university is a club that aims to familiarize students with reading comprehension of medical journal articles and promote the sharing of ideas …

The Journal Club of the Faculty of Medicine Diponegoro university is a club that aims to familiarize students with reading comprehension of medical journal articles and promote the sharing of ideas and open discussion

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,835
On Slideshare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. THE JOURNAL CLUB 1ST MEETING – 24 MAY 2012Faculty of Medicine Diponegoro University Course Supervisor: RN Tunjungputri, MD
  • 2. Group 1 Why do you think that we would like to have an HIV vaccine? What is the difficulty in producing an HIV vaccine and in controlling the immune system against HIV? Why did the previous attempts of HIV vaccines were unsuccessful? Can a vaccine that induce cytotoxic T lymphocyte prevent HIV infection? Is “herd effect” immunity in T-cell vaccine for HIV can be achieved? What does the article suggest should be done to find an effective HIV vaccine?Article:Johnston MI, Fauci AS. An HIV vaccine--challenges and prospects. N Engl JMed. 2008 Aug 28;359(9):888-90.http://1.usa.gov/MZ5ypl
  • 3. Group 2 Why does the knowledge and strategies to produce effective vaccines for many viral diseases cannot be applied to HIV? What is the goal of HIV vaccine? What strategy is most appropriate for designing HIV vaccine? What is a “structure-based vaccine design” for developing vacccines? What is the challenge of this approach? Please explain in your own words! Based on this article, what is a likely approach in designing an effective HIV vaccine?ArticleN Engl J Med. 2011 Sep 8;365(10):873-5. HIV vaccine development--improvingon natural immunity. Johnston MI, Fauci AS.http://1.usa.gov/OohmyN
  • 4. Group 3 Why is there still high HBV infection rate? Please explain the epidemiology of HIV and HBV co-infection around the world! Which specific population are highly affected? What are the impacts of HIV-HBV co-infection in comparison with HIV or HBV infection alone? What preventive efforts can be done, and what are the challenges that is still posing difficulties in tackling this problem? What is needed to overcome the HIV-HBV co-infection problem?Article: N Engl J Med. 2012 May 10;366(19):1749-52. HIV-HBV coinfection--a global challenge. Kourtis AP, Bulterys M, Hu DJ, Jamieson DJ.http://1.usa.gov/OokAW1

×